A B S T R A C T

Background
Uterine contractions can be registered by external tocodynamometry (ET) or, after rupture of the membranes, by internal tocodynamometry (IT). Monitoring of the frequency of contractions is important especially when intravenous oxytocin is used as excessive uterine activity (hyperstimulation or tachysystole) can cause fetal distress. During induction of labour as well as during augmentation with intravenous oxytocin, some clinicians choose to monitor frequency and strength of contractions with IT rather than with ET as an intrauterine pressure catheter measures intrauterine activity more accurately than an extra-abdominal tocodynamometry device. However, insertion of an intrauterine catheter has higher costs and also potential risks for mother and child.
Objectives
To assess the effectiveness of IT compared with using ET when intravenous oxytocin is used for induction or augmentation of labour.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (11 April 2012) and PubMed (1966 to 7 March 2012 .
Selection criteria
We included all published randomised controlled trials with data from women in whom IT was compared with ET in induced or augmented labour with oxytocin. We excluded trials that employed quasi-randomised methods of treatment allocation. We found no unpublished or ongoing studies on this subject.
Data collection and analysis
Two review authors independently assessed trial eligibility and risk of bias, and independently extracted data. Data were checked for accuracy. Where necessary, we contacted study authors for additional information.
Main results
Three studies involving a total of 1945 women were included. Overall, risk of bias across the three trials was mixed. No serious complications were reported in the trials and no neonatal or maternal deaths occurred. The neonatal outcome was not statistically different between groups: Apgar score less than seven at five minutes (RR 1.78, 95% CI 0.83 to 3.83; three studies, n = 1945); umbilical artery pH less than 7.15 (RR 1.31, 95% CI 0.95 to 1.79; one study, n = 1456); umbilical artery pH less than 7.16 (RR 1.23, 95% CI 0.39 to 3.92; one study, n = 239); admission to the neonatal intensive care unit (RR 0.34, 95% CI 0.07 to 1.67; two studies, n = 489); and more than 48 hours hospitalisation (RR 0.92, 95% CI 0.71 to 1.20; one study, n = 1456). The pooled risk for instrumental delivery (including caesarean section, ventouse and forceps extraction) was not statistically significantly different (RR 1.05, 95% CI 0.91 to 1.21; three studies, n = 1945). Hyperstimulation was reported in two studies (n = 489), but there was no statistically significant difference between groups (RR 1.21, 95% CI 0.78 to 1.88).
Authors' conclusions
This review found no differences between the two types of monitoring (internal or external tocodynamometry) for any of the maternal or neonatal outcomes. Given that this review is based on three studies (N = 1945 women) of moderate quality, there is insufficient evidence to recommend the use of one form of tocodynamometry over another for women where intravenous oxytocin was administered for induction or augmentation of labour.
P L A I N L A N G U A G E S U M M A R Y
Internal versus external registration of contractions during induced or augmented labour
Induction and augmentation of labour are common procedures within obstetric practice with various indications for mother and child. When contractions are stimulated by intravenous oxytocin, registration of the frequency of contractions is important for determination of the right dosage of medication. Uterine contractions can be monitored through the abdominal wall of the mother by using a small device that is placed on the skin using a belt to hold it in position, where the device measures changes in the shape of the uterus (external tocodynamometry (ET)), or by positioning an intrauterine pressure catheter inside the uterus next to the baby (internal tocodynamometry (IT)). Use of IT is only possible after rupture of the membranes and is an easy, painless procedure done during vaginal examination by the midwife or doctor in charge. During induction or augmentation of labour with intravenous oxytocin, some clinicians choose to monitor contractions with an IT rather than with ET. An intrauterine pressure catheter measures the contractions more accurately and could result in a better dosage of the oxytocin. This could, therefore, reduce the risk of hyperstimulation, for example too frequent contractions, and subsequently reduce the risk for fetal distress. Moreover with the modern central monitoring systems and the accurate registration with the use of IT there is no need for the caregivers to be physical present in the labour room to assess the frequency of contractions. However, besides higher costs of IT, insertion of an intrauterine catheter in the uterus of the mother has rare but potentially hazardous risks for both mother and child, like placental and fetal vessel damage.
The aim of this review was to compare the effectiveness of IT compared with ET. We included three randomised controlled studies (1945 women) . The methodological quality of the studies was considered to be moderate. When comparing internal registration of contractions with external registration of contractions during induced or augmented labour, there were no differences in any of the outcomes for mother or child: adverse neonatal outcomes, instrumental deliveries, caesarean section, use of analgesia or time to delivery. No increased risk for infection was reported when an intrauterine catheter was used in these studies.
There is insufficient evidence to recommend the use of one form of tocodynamometry over another for women where intravenous oxytocin is administered for induction or augmentation of labour. 
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N
CI: Confidence interval; RR:
Risk ratio;
GRADE Working Group grades of evidence High quality:
Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality:
Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality:
Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality:
We are very uncertain about the estimate.
1
Unclear risk of bias for not blinding patients and caregivers.
2
No report of allocation concealment
3
No report of allocation concealment in two of the three trials.
B A C K G R O U N D Oxytocin in labour
Since 1906 the contractile properties of oxytocin on uterine myometrial smooth muscle has been described (Dale 1906) . Initially, an extract of the posterior pituitary was used for treatment of postpartum bleeding. Since the cloning of the gene in 1983, synthetic oxytocin is now produced in different forms by pharmaceutical companies (Land 1983) . Oxytocin is usually administered in a diluted intravenous infusion; it cannot be administered orally because it is quickly metabolized in the gastrointestinal tract. 
Oxytocin complications
Potential complications caused by the use of intravenous oxytocin for induction or augmentation of labour are hyponatraemia, hypotension and hyperstimulation (Smith 2006) . Hyponatraemia is an electrolyte disturbance in which the sodium concentration in the serum is below 135 mEq/L. Excessive uterine activity (hyperstimulation or tachysystole) is defined by the American College of Obstetricians and Gynecologists (ACOG) as more than five contractions in 10 minutes, lasting at least two minutes, or contractions of normal duration within one minute of each other (ACOG 2009). When contractions are too frequent, the recovery period between contractions shortens and this may affect fetal oxygenation, cause fetal hypoxia and even lead to brain damage. On the other hand, signs of fetal hypoxia increase the risk for instrumental delivery and consequently iatrogenic damage to mother and child. Reducing the risk of hyperstimulation and thus fetal hypoxia by accurate measurement of contractions could therefore lead to a reduction in fetal and maternal morbidity.
Internal tocodynamometry complications
Intrauterine pressure catheter placement, a routine procedure in labour and delivery, has the possibility of infrequent but potentially hazardous risks for mother and child. Insertion of an intrauterine catheter during labour is usually an easy procedure to accomplish. In the literature, however, there have been reports of an increased risk of intrauterine infections and repeated case reports of placental or fetal vessel damage despite management lege artis (Soper 1989; Handwerker 1995; Soper 1996; Lind 1999; Wilmink 2008) . Extramembranous placement occurs 14% to 38% of the time (Lind 1998), with adverse events occurring in one in 1400 placements (Chan 1973; Trudinger 1978) . More recently two cases were reported with an anaphylactoid syndrome of pregnancy, previously known as amniotic fluid embolism, after Intrauterine pressure catheter placement. This was expressed as a life threatening anaphylactic reaction with acute onset of severe hypoxia, neurologic sequelae, and haemodynamic collapse with subsequent cardiopulmonary failure followed by disseminated intravascular coagulation (Matsuo 2008; Harbison 2010) .
Internal tocodynamometry versus external tocodynamometry
Uterine contractions can be assessed by palpation of the fundus of the uterus and observation of the mother. With this method the obstetrician gets a snapshot and no long term hard copy registration of the contraction in relation to the fetal heart rate. Therefore, this method will not be included. External tocodynamometry (ET) is a method that continuously records contractions by using a belt to place a transducer on the fundus; these recordings are affected by maternal movements. ET measures the change of the shape of the uterus in relation to the abdominal wall during a contraction. This method is used to measure the frequency of the contractions, but not the intrauterine change of pressure. Internal tocodynamometry (IT) monitors uterine activity with a strain gauge (an intrauterine pressure catheter) inserted into the cavity of the uterus next to the fetus, which provides data on the frequency and duration of uterine contractions. Insertion of an intrauterine pressure catheter is done during a vaginal examination and is a simple procedure that is carried out by both midwives and doctors. The device measures the intrauterine pressure, expressed in Montevideo units, at rest and during contractions. All methods provide good information on the frequency of contractions and an indication of their duration. Both during induction of labour as well as augmentation, some clinicians choose to monitor the frequency and strength of contractions with IT rather than ET, as IT measures intrauterine activity more accurately (Bakker 2008) . There are several arguments in favour of IT.
1. When using oxytocin, exact monitoring of contractions is demanded in order to prevent hyperstimulation. ET does not accurately register contractions in all women and in all positions of the labouring woman so it can underestimate the uterine contractions, which may lead to excessive use of oxytocin and thus hyperstimulation. Some state that the use of IT, by accurately measuring uterine contractions, leads to a more moderate amount of oxytocin and reduces the risk of hyperstimulation.
2. Among women in their child bearing years, 8% have severe obesity with a body mass index above 40 kg/m 2 (Euliano 2007). This group have more obstetric complications such as preeclampsia and gestational diabetes. Induction of labour is common in this group of women and uterine activity can be difficult to assess with ET. The distance from the external tocodynamometer on the skin to the uterine wall could be such that reliable measurement of uterine contractions is not possible. IT could therefore be more useful in this group of women.
3. Some argue that the use of IT might facilitate the clinical diagnosis of uterine rupture, especially in women with a previous caesarean section, because the expectation is that the pressure inside the uterine cavity flattens and lowers when the uterine wall is ruptured. This, however, is not supported by the literature (Rodriquez 1989) . In this review of 76 cases of uterine rupture, 39 were monitored with an intrauterine pressure catheter. The classic description of a loss of intrauterine pressure or cessation of labour was not observed in any of the patients. Furthermore, routine use of IT in every induced or augmented woman is costly as the rates of induction and augmentation are increasing. Labour induction rates in the United States has risen from less than 10% of deliveries to more than 22% between 1990 and 2008; and augmentation took place in more than 20% of all deliveries in 2008 according to data from the Centers for Disease Control and Prevention (Osterman 2011) . Routine use of IT in 40% of all deliveries would add significant public health costs, of roughly USD 200 million/year.
O B J E C T I V E S
The primary aim of this review was to evaluate the effectiveness of internal tocodynamometry (IT) compared with external tocodynamometry (ET) when intravenous oxytocin is used for induction or augmentation of labour.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all published, unpublished and ongoing randomised controlled trials in which IT was compared with external monitoring or no monitoring in women undergoing induction or augmentation of labour with oxytocin. Cluster-randomised trials and trials using a crossover design were excluded. We excluded trials that employed quasi-randomised methods of treatment allocation.
Types of participants
Pregnant women undergoing induction of labour or augmentation of labour with intravenous oxytocin.
Types of interventions
Insertion of all types of intrauterine pressure catheters during labour compared with ET or no monitoring.
Types of outcome measures Primary outcomes
• Uterine rupture • Hyperstimulation • Apgar score less than seven at five minutes • Umbilical artery pH • Admission of newborn to neonatal intensive care unit
Secondary outcomes
These included other measures of effectiveness, complications and health service use. 5. weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the 'Specialized Register' section within the editorial information about the Cochrane Pregnancy and Childbirth Group. Trials identified through the searching activities described above were each assigned to a review topic (or topics). The Trials Search Coordinator searched the register for each review using the topic list rather than keywords. In addition, we searched PubMed (1966 to 7 March 2012) using the search terms detailed in Appendix 1. We did not apply any language restrictions.
Data collection and analysis
Selection of studies
Two review authors, PF Jansen (PJ) and JJH Bakker(JB), independently assessed all the potential studies identified as a result of the search strategy. BY van der Goes (BG) was asked to assess the Bakker 2010 trial as she was not involved in the conducting or writing up of this study. Disagreements were resolved through discussion.
Data extraction and management
We designed a form to extract data. For eligible studies, two review authors PJ and JB independently extracted the data using the agreed form. For the Bakker 2010 trial, co-author BG was asked to extract data from the trial. We resolved discrepancies through discussion. We used the Review Manager software (RevMan 2011) to double enter all the data, or a subsample. When information regarding any of the above was unclear, we attempted to contact the authors of the original reports for them to provide additional information or data.
Assessment of risk of bias in included studies
Two authors (PJ and JB) independently assessed the risk of bias for each study using the criteria outlined in section 8 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). There was no disagreement. We considered two major sources of potential bias and the methods of avoidance of these biases when assessing trial quality. Moreover, we looked specifically at declared sample size calculations, defined inclusion and exclusion criteria, baseline comparability and whether a conflict of interest was present, absent or unclear.
(1) Random sequence generation (checking for possible selection bias)
We described for each included study the method used to generate the allocation sequence to allow an assessment of whether it should produce comparable groups. We assessed the method as:
• low risk of bias (any truly random process, e.g. random number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection bias)
We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or nonopaque envelopes; alternation; date of birth);
(3.1) Blinding of participants and personnel (checking for possible performance bias)
We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel. We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)
We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total number of randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re-included missing data in the analyses which we undertook. We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; 'as treated' analysis done with substantial departure of the intervention received from that assigned at randomisation);
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.
• low risk of bias (where it was clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been reported);
• high risk of bias (where not all the study's pre-specified outcomes have been reported; one or more reported primary outcome was not pre-specified; outcomes of interest were reported incompletely and so cannot be used; study failed to include results of a key outcome that would have been expected to have been reported);
(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)
We described for each included study any important concerns we had about other possible sources of bias.
We assessed whether each study was free of other problems that could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there was a risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the Handbook for Systematic Reviews of Interventions (Higgins 2011). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses (see Sensitivity analysis).
Measures of treatment effect
We carried out statistical analysis using the Review Manager software (RevMan 2011). We used fixed-effect model meta-analysis for combining data in the absence of significant heterogeneity if trials were sufficiently similar. If heterogeneity was found, this was explored by sensitivity analysis followed by use of a random-effects model if required. Probable causes of heterogeneity could be the body mass index (BMI) of the woman in labour, parity, gestational age and birthweight.
Dichotomous data
For dichotomous data, we presented results as summary relative risk with 95% confidence interval.
Continuous data
For continuous data, we used the median as outcomes were measured in the same way between trials.
Dealing with missing data
For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. For all outcomes we carried out analyses, as far as possible, on an intention-to-treat basis. That is, we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using the T², I² and Chi² statistics. We regarded heterogeneity as substantial if I² was greater than 30% and either T² was greater than zero or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.
Assessment of reporting biases
In future updates of this review, if there are 10 or more studies in the meta-analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually, and also use formal tests for funnel plot asymmetry. For continuous outcomes we will use the test proposed by Egger 1997, and for dichotomous outcomes we will use the test proposed by Harbord 2006. If asymmetry is detected in any of these tests or is suggested by a visual assessment, we will perform exploratory analyses to further investigate the causes.
Data synthesis
We carried out statistical analysis using the Review Manager software (RevMan 2011). We used fixed-effect model meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect; that is where trials were examining the same intervention, and the trials' populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects would differ between trials, or if substantial statistical heterogeneity was detected, we explored the reason for the heterogeneity by subgroup analysis. We discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful we did not combine trials.
Subgroup analysis and investigation of heterogeneity
If we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful and, if it was, used randomeffects model meta-analysis to produce it. We planned to carry out the following subgroup analyses for the outcome 'duration of labour': 1. induction of labour; 2. augmentation of labour. We planned to carry out subgroup analysis in the group of women with a previous caesarean section. For fixed-effect model inverse variance meta-analyses we assessed differences between subgroups by interaction tests. For randomeffects and fixed-effect model meta-analyses using methods other than inverse variance, we assessed differences between subgroups by inspection of the confidence intervals; non-overlapping confidence intervals indicate a statistically significant difference in treatment effect between the subgroups.
Sensitivity analysis
In future updates of this review, as more data become available, we will carry out sensitivity analysis to explore the effect of trial quality if trials of differing quality are included in the review. This will involve analysis based on our assessment of whether trials are at risk of selection bias or attrition bias. Studies of poor quality (those rated as 'high' or 'unclear' risk of bias for sequence generation, allocation concealment, or incomplete outcome data) will be excluded in the analysis in order to assess any substantive difference compared to the overall result.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies.
Results of the search
The search of the Pregnancy and Childbirth Group Trials Register found 14 reports and our search of PubMed found 189. After screening the titles and abstracts we selected 25 reports of 19 studies. We included three and excluded 16 titles. Two review authors (PJ and JB) independently assessed all the potential studies identified as a result of the search strategy. Both authors used a data form to assess the quality of the studies and extract data from the included studies. There were four potentially eligible randomised controlled trials with a randomised comparison of external tocodynamometry (ET) and internal tocodynamometry (IT). We found no unpublished or ongoing studies on this subject.
Included studies
We included three studies (Chua 1990; Chia 1993; Bakker 2010) involving 1945 women. Furthermore we used the report of van Halem 2011, a follow up of the randomised controlled trial of Bakker 2010, that contained data for the infection outcome. The two studies of Chia and Chua were performed in Singapore, and the third study was performed in the Netherlands. All studies were in hospital settings. The methodological quality of the trials was considered good. The three randomised controlled trials had good comparable methods and outcomes. In the trials of Chia 1993 and Chua 1990 it remained unclear whether the study population included women with a previous caesarean section. In the trial of Bakker 2010 women with a previous caesarean section were excluded. For details of the included studies, see the table Characteristics of included studies.
Excluded studies
We excluded 16 studies. There were many publications about intra-and extramembranous placement of the catheter, differences between different types of catheters and case reports about adverse events. We did not include these studies in this review but focused on the randomised comparison of ET and IT. We agreed to exclude one study that compared ET and IT, the study of Panayotopoulos 1998, because of the invalid randomisation method, which involved selecting every second case and ended up with two unequal study groups. We did not identify any studies comparing tocodynamometry with no monitoring. For details of excluded studies, see the table Characteristics of excluded studies.
Risk of bias in included studies
Allocation
The Bakker 2010 trial used a central, computerised randomisation program that provided the allocation of included women at the different study sites, so it was ensured that the sequence was concealed. Women in the studies of Chia 1993 and Chua 1990 were randomly allocated to the different methods of tocography by using a random number table; this method was acceptable at the time and has a low risk of selection bias. Chia 1993 and Chua 1990 reported no losses to follow up and they did not keep a record of eligible non-randomised women. The trial by Bakker 2010 reported no losses to follow up cases but had a substantial number of non-participants. More than 72% of the eligible women declined participation or were not informed about the trial due to various reasons, mostly workload of the caregivers (information first author). We judged adequate generation of the randomisation sequence in all three trials and the risk for bias was low.
Blinding
Due to the nature of the interventions, in all included studies the allocation was not blinded for the doctor or the women. Although it is highly unlikely that women or caregiver knowledge of the allocation could influence outcomes, the lack of blinding downgraded the level of quality assessment of findings. In the study of van Halem 2011, the assessor of the medical files was blinded to the allocation.
Incomplete outcome data
The trial by Bakker 2010 reported the outcomes according the intention-to-treat principle, that is the women were analysed in the group they were allocated to; and also according to the per protocol principle, that is the women were analysed in the group with the treatment they actually received. Chia 1993 and Chua 1990 reported no crossover in their study groups. For the pooled risk we used the data from the intention-to-treat analysis.
Selective reporting
The included studies had clear and specific pre-specified outcomes and so appeared to be free of selective reporting. The trial by Bakker 2010 did not report the outcome hyperstimulation. In the study protocol published in the trials register this outcome was not planned.
Effects of interventions
See: Summary of findings for the main comparison Monitoring of contractions with internal tocodynamometry compared to external tocodynamometry
Primary outcomes
Uterine rupture did not occur in any of the three trials. Hyperstimulation was reported in two of the included trials, Chia 1993 and Chua 1990 (involving 489 women), but was not different between the study groups (risk ratio (RR) 1.21, 95% confidence interval (CI) 0.78 to 1.88; Analysis 1.2). The neonatal outcome was no different between the control group which used ET and the intervention group which used an intrauterine pressure catheter. An Apgar score less than seven at five minutes was reported in all included trials and was not statistically significantly different between groups (RR 1.78, 95% CI 0.83 to 3.83; N = 1945; Analysis 1.3). Umbilical artery pH less than 7.15 was reported in one trial (Bakker 2010) (RR 1.31, 95% CI 0.95 to 1.79; N = 1456; Analysis 1.4); pH less than 7.16 was reported in the trial of Chia 1993 (RR 1.23, 95% CI 0.39 to 3.92;N = 239; Analysis 1.6). Admission to the neonatal intensive care unit was reported in two studies (Chua 1990; Chia 1993 ) and was not statistically significantly different between groups (RR 0.34, 95% CI 0.07 to 1.67; N = 489; Analysis 1.7). One study (Bakker 2010) reported more than 48 hours hospitalisation instead (RR 0.92, 95% CI 0.71 to 1.20; N = 1456; Analysis 1.8).
Secondary outcomes
There were no serious complications, like placenta or vessel perforation, or abruptio placentae, reported in the trials from the use of the intrauterine pressure catheter, and no neonatal deaths or serious maternal complications (defined as death, coma, cardiac arrest, respiratory arrest, use of a mechanical ventilator, admission to intensive care unit) occurred in either study group. All three studies reported rates of instrumental vaginal delivery and caesarean section. The pooled risk for instrumental delivery (caesarean section, ventouse and forceps extraction) was not statistically significant different (RR 1.05, 95% CI 0.9 to 1.2; three studies, N = 1945; Analysis 1.11). There was variance between the studies. The differences in crude percentages between the studies were probably due to the different policies and increasing interventions in obstetrics over time (1993 versus 2010) , but most of all the variance was due to different etiology: induced labour versus augmented labour in cases of arrest of labour. Therefore, we performed a subgroup analysis. The pooled risk for instrumental delivery for women with induced labour was more in favour of IT yet not statistically significantly different (RR 0.91, 95% CI 0.75 to 1.1; two studies, N = 1195; Analysis 1.11). The pooled risk for instrumental delivery for women with augmented labour, however, was in favour of ET and just statistically significantly different (RR 1.25, 95% CI 1.02 to 1.5; two studies, N = 750; Analysis 1.11). The interaction test for subgroup differences was significant for this subgroup analysis (P = 0.02; Analysis 1.11) suggesting a difference between the induced and augmented subgroups. When the risk for instrumental delivery was specified as vaginal instrumental delivery or operative delivery (that is caesarean section) the difference between the augmented group women and the induced group women disappeared. The pooled risk for a caesarean section was not statistically significant between study groups (RR 1.04, 95% CI 0.85 to 1.29; three studies, N = 1945; Analysis 1.13). This CI corresponds to a plausible reduction of the caesarean section rate of 15% up to a nearly 30% increase. The risk for caesarean section was not different between the subgroups. The pooled risk for vaginal instrumental deliveries (ventouse or forceps extraction) was not statistically significant different (RR 1.06, 95% CI 0.85 to 1.32; three studies, N = 1945; Analysis 1.12). There was no increased risk of infection when an intrauterine catheter was used: infection during labour (RR 0.69, 95% CI 0.44 to 1.08; one study, N = 1456; Analysis 1.17), and no increased risk of infection in mother or child up to three weeks postpartum (van Halem 2011) (RR 0.84, 95% CI 0.61 to 1.16; one study, N = 1435; Analysis 1.16). For the outcome "infection up to three weeks postpartum", women with an indication for prophylactic antibiotic during labour (i.e. for known positive Group B streptococcus (GBS) status, heart disease, or other reasons for prophylaxis) were excluded for analysis. Median times to delivery in the subgroups induced and augmented labour were not statistically significantly different between study groups (see Table 1 ). Mean time to delivery was extracted for this review from the dataset of the Bakker 2010 trial, no statistically significant difference was found between the groups (mean difference (MD) -15.60 minutes, 95% CI -40.99 to 9.79; 1 study, N = 1456; Analysis 1.14). Other secondary outcomes were not reported (antepartum or postpartum haemorrhage, duration of hospital stay for mother or child, women's satisfaction; specified neonatal outcomes like respiratory distress syndrome, use of mechanical ventilation, intraventricular haemorrhage, neonatal jaundice or sepsis; total hospital costs, use of health service). No subgroup analysis could be performed for women with a previous caesarean section.
D I S C U S S I O N
The aim of this review was to compare the effectiveness of IT compared with ET. We included three randomised controlled studies (1945 women) of moderate quality. The results suggest no benefit for the routine use of internal tocodynamometry (IT) for monitoring contractions in women with induced or augmented labour with intravenous oxytocin. However, there is insufficient evidence to recommend the use of one form of tocodynamometry over another form for women where intravenous oxytocin is administered for induction or augmentation of labour.
Summary of main results
Three studies were included in this review. Although on theoretical grounds one might expect a better neonatal outcome and a more effective stimulation when the contractions are accurately measured, the robust results of the included studies do not support this concept. The pooled risk for instrumental delivery was not statistically different between study groups, however in the subgroup of women with augmented labour there was a just statistically significant difference in favour of ET. When the variable instrumental delivery was specified into instrumental vaginal delivery or caesarean section, this benefit for ET was not found; moreover we lack a clinical explanation for a possible advantage of external registration of contractions when labour is augmented. This review found insufficient evidence for a benefit of the routine use of IT on rates of adverse neonatal outcomes, rates of instrumental deliveries, use of analgesia, infection, or time to delivery. Moreover, case reports state that IT has rare but serious risks, including placental or fetal-vessel damage, infection and anaphylactic shock.
In this review involving 922 women who were monitored with IT tocodynamometry, no such events occurred.
Overall completeness and applicability of evidence
In the Bakker 2010 trial, 12% of the women assigned to external monitoring were nonetheless treated with an intrauterine pressure catheter at the physician's discretion. The protocol of this study permitted crossover if cervical progression was absent for two hours, the frequency of uterine contractions was not sufficient, or caesarean section was being considered. These 12% of women were more likely to be primiparous (82.6% versus 63.2%), had a higher mean pre-pregnancy BMI (27.4 versus 25.3), and were more likely to have hypertension or pre-eclampsia (33.8% versus 10.3%); they were also more likely to have a caesarean section (33.0% versus 16.0%). Analysis per protocol, for example according to the treatment actually given, had similar results in the rate of operative deliveries and for adverse neonatal outcomes. The two smaller studies (Chua 1990; Chia 1993) did not report crossover between study groups. The study population of this review included women who were treated with intravenous oxytocin to stimulate contractions but did not involve women with a previous caesarean section. Whether an intrauterine pressure catheter should be used in these women is still controversial. Some clinicians state that the risk for uterus rupture is increased because of insertion of the catheter; others advocate the use of IT in women with a previous caesarean section, because they expect that the diagnosis of uterus rupture is easier. This review does not answer this question for this subgroup of women.
Quality of the evidence
The methodological quality of the trials was considered moderate.
Potential biases in the review process
We acknowledge that there is always a possibility of introducing bias at every stage of the review process. We attempted to minimise bias in a number of ways; two review authors independently assessed eligibility for inclusion and risk of bias, and carried out data extraction; moreover, assessment and data extraction of the largest trial (Bakker 2010) was done by a review co-author (BG) who was not involved in the trial.
Agreements and disagreements with other studies or reviews
The three included studies agree in their conclusion that there is no benefit with routine IT.
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is insufficient evidence to recommend the use of one form of tocodynamometry over another for women where intravenous oxytocin is administered for induction or augmentation of labour.
In women with lack of progress of labour, cervical progression absent for two hours, or unclear frequency of uterine contractions, one-to-one observation of the labouring woman and her contractions is a realistic alternative to IT in the absence of a non-invasive alternative.
Implications for research
Future trials could focus on examining the strength of contractions during labour by improving the quality of extra-abdominal methods. These trials should include hyperstimulation and women's satisfaction.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by year of study]
Chua 1990
Methods Randomised controlled trial.
Participants 250 women with spontaneous onset of labour, slow progress and the indication for augmentation with oxytocin 
Risk of bias
Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk Quote: "Randomisation was done by a computer program".
Allocation concealment (selection bias) Low risk Allocation was concealed because of the computerized method of randomisation with use of a minimisation method Sequence was generated at a central location in the department of epidemiology Test for subgroup differences: Chi 2 = 2.15, df = 1 (P = 0.14), I 2 =54% 
A D D I T I O N A L T A B L E S
